B. M. Stadtmueller

Structural and biochemical requirements for secretory component interactions with dimeric Immunoglobulin A

This study identifies key residues in secretory component domains D1 and D3 and JC C-terminal residues that mediate binding to dIgA and stabilize SIgA structure.

Engineered Secretory Immunoglobulin A provides insights on antibody-based effector mechanisms targeting Clostridiodes difficile

This study engineers chimeric SIgA to investigate and enhance effector mechanisms against C. difficile, showing increased neutralization and bacterial clumping.

Suppression of epithelial proliferation and tumorigenesis by immunoglobulin A

This study shows that IgA suppresses epithelial proliferation and tumorigenesis by interacting with DMBT1, highlighting its role in maintaining mucosal homeostasis.

Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain

The paper identifies two public IGHV3-53/3-66 clonotypes with distinct CDR H3 motifs and shows Y58F mutation enhances binding affinity to SARS-CoV-2 RBD.